Kurt Losert, CEO

Kurt Losert was named CEO of FCF in October 2022. He is a graduate of Princeton University and Harvard Business School. He has been active in the fibrolamellar patient and caregiver community since 2004, when his wife, Elisabeth, was diagnosed with the disease. In addition to facing the loss of his wife, Kurt brings to FCF experience as a management consultant and technology executive, having worked for McKinsey & Company, Compaq Computer Corporation and several small internet, software and services companies. Kurt is the father of two adult children.